Delayed
Australian S.E.
11:20:27 25/06/2024 am IST
|
5-day change
|
1st Jan Change
|
1.128
AUD
|
-1.10%
|
|
-0.66%
|
-23.30%
|
Fiscal Period: June |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
447.4
|
740.1
|
641.5
|
-
|
-
|
Enterprise Value (EV)
1 |
467
|
1,436
|
1,091
|
1,104
|
1,123
|
P/E ratio
|
-
|
-
|
-
|
-
|
-
|
Yield
|
5.45%
|
5.8%
|
7.04%
|
7.23%
|
7.75%
|
Capitalization / Revenue
|
15.4
x
|
15.5
x
|
9.73
x
|
9.91
x
|
9.49
x
|
EV / Revenue
|
16
x
|
30.1
x
|
16.5
x
|
17.1
x
|
16.6
x
|
EV / EBITDA
|
24.5
x
|
48.5
x
|
17.8
x
|
16
x
|
15.4
x
|
EV / FCF
|
19.8
x
|
63.3
x
|
50.5
x
|
36.9
x
|
20.6
x
|
FCF Yield
|
5.05%
|
1.58%
|
1.98%
|
2.71%
|
4.86%
|
Price to Book
|
0.68
x
|
0.78
x
|
0.67
x
|
0.66
x
|
0.65
x
|
Nbr of stocks (in thousands)
|
3,25,378
|
5,62,814
|
5,62,693
|
-
|
-
|
Reference price
2 |
1.375
|
1.315
|
1.140
|
1.140
|
1.140
|
Announcement Date
|
11/08/22
|
14/08/23
|
-
|
-
|
-
|
Fiscal Period: June |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
29.14
|
47.7
|
65.95
|
64.73
|
67.59
|
EBITDA
1 |
19.1
|
29.6
|
61.16
|
68.93
|
73.01
|
EBIT
1 |
17.47
|
29.6
|
62.34
|
69.55
|
72.78
|
Operating Margin
|
59.94%
|
62.05%
|
94.52%
|
107.44%
|
107.67%
|
Earnings before Tax (EBT)
|
49.61
|
-
|
-
|
-
|
-
|
Net income
|
-
|
20.2
|
-
|
-
|
-
|
Net margin
|
-
|
42.35%
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
23.59
|
22.7
|
21.6
|
29.9
|
54.6
|
FCF margin
|
80.95%
|
47.59%
|
32.75%
|
46.19%
|
80.78%
|
FCF Conversion (EBITDA)
|
123.49%
|
76.69%
|
35.32%
|
43.38%
|
74.79%
|
FCF Conversion (Net income)
|
-
|
112.38%
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0750
|
0.0762
|
0.0802
|
0.0824
|
0.0883
|
Announcement Date
|
11/08/22
|
14/08/23
|
-
|
-
|
-
|
Fiscal Period: June |
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
---|
Net sales
1 |
10.84
|
18.29
|
-
|
-
|
39.6
|
EBITDA
1 |
-
|
-
|
-
|
18.4
|
29.1
|
EBIT
1 |
4.423
|
11.39
|
10.6
|
18.4
|
29.1
|
Operating Margin
|
40.79%
|
62.25%
|
-
|
-
|
73.48%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
1.542
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
0.004700
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
0.0388
|
0.0400
|
Announcement Date
|
17/02/22
|
11/08/22
|
16/02/23
|
14/08/23
|
12/02/24
|
Fiscal Period: June |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
19.6
|
696
|
449
|
463
|
481
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.026
x
|
23.52
x
|
7.346
x
|
6.71
x
|
6.593
x
|
Free Cash Flow
1 |
23.6
|
22.7
|
21.6
|
29.9
|
54.6
|
ROE (net income / shareholders' equity)
|
2.42%
|
2.52%
|
5.39%
|
4.94%
|
5.16%
|
ROA (Net income/ Total Assets)
|
-
|
1.67%
|
2.44%
|
3.11%
|
3.86%
|
Assets
|
-
|
1,209
|
-
|
-
|
-
|
Book Value Per Share
2 |
2.010
|
1.690
|
1.700
|
1.730
|
1.760
|
Cash Flow per Share
2 |
0.0700
|
0.0600
|
0.0400
|
0.0700
|
0.0800
|
Capex
1 |
-
|
-
|
-
|
1
|
2
|
Capex / Sales
|
-
|
-
|
-
|
1.54%
|
2.96%
|
Announcement Date
|
11/08/22
|
14/08/23
|
-
|
-
|
-
|
Last Close Price
1.14
AUD Average target price
1.492
AUD Spread / Average Target +30.89% Consensus |
1st Jan change
|
Capi.
|
---|
| -23.30% | 427M | | +14.20% | 61.57B | | +1.71% | 20.48B | | -0.76% | 13.83B | | +9.59% | 8.3B | | -5.86% | 6.19B | | +11.89% | 3.62B | | +4.84% | 3.46B | | -8.64% | 2.97B | | +20.54% | 2.92B |
Healthcare REITs
|